Genes up-regulated in MCF7 cells (breast cancer) after stimulation with EGF [GeneID=1950].
| PAG Title | Genes up-regulated in MCF7 cells (breast cancer) after stimulation with EGF [GeneID=1950]. |
| PAG ID | MAX002044 |
| Type | A |
| Source Link |  MSigDB |
| Publication Reference | NA |
| PAG Description | ErbB receptor ligands, epidermal growth factor (EGF) and heregulin (HRG), induce dose-dependent transient and sustained intracellular signaling, proliferation, and differentiation of MCF-7 breast cancer cells, respectively. In an effort to delineate the ligand-specific cell determination mechanism, we investigated time course gene expressions induced by EGF and HRG that induce distinct cellular phenotypes in MCF-7 cells. To analyze independently the effects of ligand dosage and time for gene expression, we developed a statistical method for estimating the two effects. Our results indicated that signal transduction pathways convey quantitative properties of the dose-dependent activation of ErbB receptor to early transcription. The results also implied that moderate changes in the expression levels of a number of genes, not the predominant regulation of a few specific genes, might cooperatively work at the early stage of the transcription for determining cell fate. However, the EGF- and HRG-induced distinct signal durations resulted in the ligand-oriented biphasic induction of proteins after 20 min. The selected gene list and HRG-induced prolonged signaling suggested that transcriptional feedback to the intracellular signaling results in a graded to biphasic response in the cell determination process and that each ErbB receptor is inextricably responsible for the control of amplitude and duration of cellular biochemical reactions. |
| Species | Homo sapiens |
| Quality Metric Scores | nCoCo Score: 511 |
| Information Content | Rich |
| Other IDs | M16311 |
| Base PAG ID | MAX002044 |
| Human Phenotyte Annotation | |
| Curator | PAGER curation team |
| Curator Contact | PAGER-contact@googlegroups.com |
">
Something else? Please send us an email!